The matching of electrostatic extrema: A useful method in drug design? A study of phosphodiesterase III inhibitors
暂无分享,去创建一个
Jeremy G. Vinter | J. G. Vinter | Sarah L. Price | Robert P. Apaya | Baldo Lucchese | S. Price | Baldo Lucchese | R. Apaya
[1] Harel Weinstein,et al. Electrostatic Potentials as Descriptors of Molecular Reactivity: The Basis for Some Successful Predictions of Biological Activity , 1981 .
[2] M. Venuti,et al. Inhibitors of cyclic AMP phosphodiesterase. 3. Synthesis and biological evaluation of pyrido and imidazolyl analogues of 1,2,3,5-tetrahydro-2-oxoimidazo[2,1-b]quinazoline. , 1988, Journal of medicinal chemistry.
[3] Edward E. Hodgkin,et al. Molecular similarity based on electrostatic potential and electric field , 1987 .
[4] D. B. Evans,et al. Cardiotonic agents. 1. 4,5-Dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3 (2H)-pyridazinones: novel positive inotropic agents for the treatment of congestive heart failure. , 1984, Journal of medicinal chemistry.
[5] J. G. Vinter,et al. Crystal and molecular structures of pyridazinone cardiovascular agents. , 1994, Acta crystallographica. Section B, Structural science.
[6] H Weinstein,et al. QUANTUM CHEMICAL STUDIES ON MOLECULAR DETERMINANTS FOR DRUG ACTION * , 1981, Annals of the New York Academy of Sciences.
[7] P. Kollman,et al. An all atom force field for simulations of proteins and nucleic acids , 1986, Journal of computational chemistry.
[8] Peter Politzer,et al. Chemical Applications of Atomic and Molecular Electrostatic Potentials: "Reactivity, Structure, Scattering, And Energetics Of Organic, Inorganic, And Biological Systems" , 2013 .
[9] C. Humblet,et al. Cardiotonic agents. 8. Selective inhibitors of adenosine 3',5'-cyclic phosphate phosphodiesterase III. Elaboration of a five-point model for positive inotropic activity. , 1987, Journal of medicinal chemistry.
[10] Adriaan P. IJzerman,et al. Relative binding orientations of adenosine A1 receptor ligands — A test case for Distributed Multipole Analysis in medicinal chemistry , 1995, J. Comput. Aided Mol. Des..
[11] Ramon Carbo,et al. How similar is a molecule to another? An electron density measure of similarity between two molecular structures , 1980 .
[12] Ferran Sanz,et al. MEPSIM: A computational package for analysis and comparison of molecular electrostatic potentials , 1993, J. Comput. Aided Mol. Des..
[13] Jeremy G. Vinter,et al. Extended electron distributions applied to the molecular mechanics of some intermolecular interactions , 1994, J. Comput. Aided Mol. Des..
[14] A. Davis,et al. Strategic approaches to drug design. II. Modelling studies on phosphodiesterase substrates and inhibitors , 1987, J. Comput. Aided Mol. Des..
[15] Sarah L. Price,et al. The electrostatic interactions in van der Waals complexes involving aromatic molecules , 1987 .
[16] E. Beedle,et al. Bipyridine cardiotonics: the three-dimensional structures of amrinone and milrinone. , 1986, Journal of medicinal chemistry.
[17] Patrick W. Fowler,et al. A model for the geometries of Van der Waals complexes , 1985 .
[18] Sarah L. Price,et al. Electrostatic models for polypeptides: can we assume transferability? , 1992 .
[19] Sarah L. Price,et al. The effect of basis set and electron correlation on the predicted electrostatic interactions of peptides , 1992 .
[20] N P Peet,et al. A novel synthesis of xanthines: support for a new binding mode for xanthines with respect to adenosine at adenosine receptors. , 1990, Journal of medicinal chemistry.
[21] Anthony J. Stone,et al. Distributed multipole analysis, or how to describe a molecular charge distribution , 1981 .
[22] Yuichi Kato,et al. Automatic superposition of drug molecules based on their common receptor site , 1992, J. Comput. Aided Mol. Des..